Release Date: 30/01/15 17:14 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 293.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%